News

Company will now have three operational centers across the US

Further internationalization of its mission will occur in 2019; Novartis is honored

Virtual assistants delivering guidance from Accenture’s Intelligent Patient Platform

Accreditation status is both an entry ticket and a competitive measure for specialty pharmacies to attract manufacturer attention

New product modules include medical coding and electronic data capture; a roadmap for the next few years points at more

JC Scott takes over as the PBM business undergoes a transformation

Electronic benefits verification (eBV) combines with patient access services

Westrock takes all the trophies this year with its DosePak technology

Platform will operate within IBM’s HyperLedger blockchain technology

Cellular and genetic therapies will benefit from coordinated information delivery

Ownership of supply chain data is becoming contentious

Known as the “King of Cold Chain,” Bishara looks both back and ahead at progress in upgrading pharma’s logistics practices

Pharma supply chain managers now have options for dealing with cryogenic to room-temperature ranges

More biologic-based therapies translates into more cold chain activity. As yet, new cellular and genetic therapies are a minute part of the overall market.

Will the “United States-Mexico Trade Agreement” replace Nafta?

LUG Aircargo Handling is one of a growing number of logistics providers seeking the certification

The Crēdo on Demand program provides cold-chain packaging on a rental basis

CVS and Express Scripts open more of the curtain around rebates; formulary exclusions grow

Delaying final packaging until local market demand calls for it can save money

The orphan drug will reach patients through a limited-distribution network of specialty pharmacies

HDA issues a report detailing recalls and returns

The year-old-plus litigation highlights the value of customer master data

Alliance for Regenerative Medicine tries to rationalize how payers address economic value

Rare diseases are hard to treat; supporting the patient can be even more challenging

Leading US provider will produce 70 million doses in next several months

Full agenda has been finalized

Tetraphase’s anticipated approval of an antibiotic will benefit from precise marketing targeting

Innovative device offers logistics advantages over other bulk cold-chain containers

The flood of new oncology drugs is challenging the ability of healthcare providers to determine best treatment choices

FDA working group’s effort is part of a larger move to realign drug pricing policies